SparingVision nabs funding
SparingVision, a French biotech company focused on gene therapy in ophthalmology, has raised 44.5 million euros in financing.
SparingVision, a French biotech company focused on gene therapy in ophthalmology, has raised 44.5 million euros in financing.
Copyright PEI Media
Not for publication, email or dissemination